S&P 500: 681.75 +0.1% NASDAQ 100: 601.92 +0.2% Dow Jones: 495.28 +0.1%

Richard Pzena’s HOLX Holdings & Trades

First Buy
Q3 2024
Duration Held
3 Quarters
Largest Add
Q4 2025
+4,109 Shares
Current Position
4,109 Shares
$306,079 Value

Richard Pzena's HOLX Position Overview

Richard Pzena (via Pzena Investment Management LLC) currently holds 4,109 shares of Hologic, Inc. (HOLX) worth $306,079, representing 0.00% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 3 quarters.

Based on 13F filings, Richard Pzena has maintained this position in HOLX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 4,109 shares. Largest reduction occurred in Q4 2024, reducing 3,030 shares.

Analysis based on 13F filings available since 2013 Q2

Richard Pzena's Hologic (HOLX) Holding Value Over Time

Track share changes against reported price movement

Quarterly Hologic (HOLX) Trades by Richard Pzena

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2024 +3,030 New Buy 3,030 $81.46
Q4 2024 -3,030 Sold Out 0 $0.00
Q4 2025 +4,109 New Buy 4,109 $74.49

Richard Pzena's Hologic Investment FAQs

Richard Pzena first purchased Hologic, Inc. (HOLX) in Q3 2024, acquiring 3,030 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Richard Pzena has held Hologic, Inc. (HOLX) for 3 quarters since Q3 2024.

Richard Pzena's largest addition to Hologic, Inc. (HOLX) was in Q4 2025, adding 4,109 shares worth $306,079.

According to the latest 13F filing for Q4 2025, Richard Pzena's firm, Pzena Investment Management LLC, owns 4,109 shares of Hologic, Inc. (HOLX), valued at approximately $306,079.

As of the Q4 2025 filing, Hologic, Inc. (HOLX) represents approximately 0.00% of Richard Pzena's publicly disclosed stock portfolio, making it one of their key holdings.

Richard Pzena's peak holding in Hologic, Inc. (HOLX) was 4,109 shares, as reported at the end of Q4 2025.